Ad
related to: neuromuscular junction blocking agents
Search results
Results From The WOW.Com Content Network
A depolarizing neuromuscular blocking agent is a form of neuromuscular blocker that depolarizes the motor end plate. [15] An example is succinylcholine . Depolarizing blocking agents work by depolarizing the plasma membrane of the muscle fiber, similar to acetylcholine .
The neuromuscular junction. Neuromuscular drugs are chemical agents that are used to alter the transmission of nerve impulses to muscles, causing effects such as temporary paralysis of targeted skeletal muscles. Most neuromuscular drugs are available as quaternary ammonium compounds which are derived from acetylcholine (ACh). [1]
A neuromuscular junction. Curare blocks ACh receptors (bottom left). Curare is an example of a non-depolarizing muscle relaxant that blocks the nicotinic acetylcholine receptor (nAChR), [24] one of the two types of acetylcholine (ACh) receptors, at the neuromuscular junction.
Most neuromuscular blockers function by blocking transmission at the end plate of the neuromuscular junction. Normally, a nerve impulse arrives at the motor nerve terminal, initiating an influx of calcium ions, which causes the exocytosis of synaptic vesicles containing acetylcholine. Acetylcholine then diffuses across the synaptic cleft.
The term "anticholinergic" is typically used to refer to antimuscarinics which competitively inhibit the binding of ACh to muscarinic acetylcholine receptors; such agents do not antagonize the binding at nicotinic acetylcholine receptors at the neuromuscular junction, although the term is sometimes used to refer to agents which do so. [3] [5]
Pancuronium is a typical non-depolarizing curare-mimetic muscle relaxant.It competitively inhibits the nicotinic acetylcholine receptor at the neuromuscular junction by blocking the binding of acetylcholine.
In Malawi, clinics could soon be running out of critical HIV medication, unable to replenish their supply since the Trump administration ordered a freeze to U.S. foreign aid. The pause has halted ...
Antinicotinic agents are classified into ganglionic blockers and neuromuscular blockers. Ganglionic blockers are of little clinical use as they act at all autonomic ganglions. [1] [2] They act by: Interfering acetylcholine release; Prolonged depolarization (depolarisation block), i.e. stimulation then block stimulation